Lakefront Biotherapeutics (LKFT) Debt to Equity (2019 - 2025)
Lakefront Biotherapeutics (LKFT) reported Debt to Equity of $0.0 for Q4 2025, down 10.47% year-over-year from $0.0 in Q4 2024, and down 10.47% quarter-over-quarter from $0.0 in Q4 2024.
Lakefront Biotherapeutics (LKFT) Debt to Equity (2019 - 2025) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 5 years of Debt to Equity data on file, last reported at $0.0 in Q4 2025.
- Debt to Equity for Q4 2025 came in at $0.0, down 10.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.0 (down 10.47% YoY), and the FY2025 annual result was $0.0, down 10.47% from the prior year.
- Debt to Equity retreated to $0.0 in Q4 2025 per LKFT's latest filing, from $0.0 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.0 in Q4 2021 and troughed at $0.0 in Q4 2025.
- A 3-year average of $0.0 and a median of $0.0 in 2024 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2021 and 2025: Debt to Equity tumbled 93.49% in 2021, then decreased 10.47% in 2025.
- A 3-year view of Debt to Equity shows it stood at $0.0 in 2021, then tumbled by 97.76% to $0.0 in 2024, then retreated by 10.47% to $0.0 in 2025.
- Business Quant data shows LKFT's Debt to Equity at $0.0 in Q4 2025, $0.0 in Q4 2024, and $0.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Dec 31, 2019 | 0.00 |